Summary
Pfizer Inc. (PFE) has filed a Form 8-K on October 19, 2006, to announce its financial results for the third quarter of 2006. The core of this filing is the incorporation by reference of a press release issued on the same date, which details the company's performance during the quarter. While the 8-K itself doesn't provide the specific financial figures, it formally registers the press release with the SEC, making it official disclosure for investors.
Key Highlights
- 1Pfizer announced its third-quarter 2006 financial results on October 19, 2006.
- 2The company filed a Form 8-K to officially report these results.
- 3The press release containing the detailed financial results for Q3 2006 is attached as Exhibit 99.
- 4This filing incorporates the press release by reference, making its contents part of the official SEC filing.
- 5Investors can find specific financial performance data, including revenue and earnings, within the referenced press release.
Frequently Asked Questions
The main purpose of this Form 8-K filing is to publicly announce and officially register Pfizer Inc.'s financial results for the third quarter of 2006 with the Securities and Exchange Commission (SEC).
The specific financial details for Pfizer's third quarter of 2006 are contained within the press release dated October 19, 2006, which is attached to this 8-K filing as Exhibit 99. This press release is incorporated by reference into the filing.
This filing was triggered by Pfizer's earnings release announcing its financial results for the third quarter of 2006.